L1CAM and ovarian cancer: Univariate survival analysis of all 138 ovarian cancer patients using the median L1CAM mRNA expression as cut-off revealed that high levels of L1CAM had an adverse prognostic impact as well for progression-free (PFS) (p=0.002) as for overall survival (OS) (p=0.009).